ReShape Lifesciences Inc RSLS fell 12.5% to $2.72 in pre-market trading. ReShape Lifesciences jumped over 35% on Thursday ...

Traws Pharma, Inc. (NASDAQ: TRAW) has unveiled key clinical efficacy data for rigosertib, showcasing its potential as a ...

The row between pharma companies and the U.K. government over rebates has intensified, with the Association of the British Pharmaceutical Industry (ABPI) calling up its members to speak on the record, ...

In trading on Tuesday, consumer staples stocks fell by 0.8%. U.S. job openings increased by 191,000 to 7.391 million in April ...

Life science companies developing bird flu vaccines and antivirals are gaining attention as the avian influenza subtype H5N1 ...

Traws Pharma, Inc. (NASDAQ: TRAW) (“Traws Pharma”, “Traws” or “the Company”), a clinical-stage biopharmaceutical company ...

Detailed price information for Traws Pharma Inc (TRAW-Q) from The Globe and Mail including charting and trades.

FDA briefing document submitted April 24, 2025 in support of a meeting to align on pathway for tivoxavir marboxil (TXM, bird flu/seasonal flu) including potential for accelerated approval ...

Traws Pharma, Inc. (NASDAQ: TRAW), a Delaware-incorporated pharmaceutical company currently valued at $9.67 million, has recently filed an 8-K with the Securities and Exchange Commission (SEC) ...

NEWTOWN, Pa., March 31, 2025 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (TRAW) (“Traws Pharma”, “Traws” or “the Company”), a clinical-stage biopharmaceutical ...